Improvement in child cancer survival rates threatened by lack of new drug
The Series is published to coincide with a special event hosted by Glenis Willmott (MEP), which will debate these issues at the EU parliament today. New regulatory approval and research strategies are urgently needed to speed the development of new,

and more »